VIB Department of Molecular Genetics, University of Antwerp, Universiteitsplein 1, 2610 Antwerpen, Belgium.
Nat Rev Neurol. 2012 Jan 24;8(2):73-85. doi: 10.1038/nrneurol.2011.227.
Hereditary sensory and autonomic neuropathies (HSANs) are a clinically and genetically heterogeneous group of disorders of the PNS. Progressive degeneration, predominantly of sensory and autonomic neurons, is the main pathological feature in patients with HSAN, and causes prominent sensory loss and ulcerative mutilations in combination with variable autonomic and motor disturbances. Advances in molecular genetics have enabled identification of disease-causing mutations in 12 genes, and studies on the functional effects of these mutations are underway. Although some of the affected proteins--such as nerve growth factor and its receptor--have obvious nerve-specific roles, others are ubiquitously expressed proteins that are involved in sphingolipid metabolism, vesicular transport, transcription regulation and structural integrity. An important challenge in the future will be to understand the common molecular pathways that result in HSANs. Unraveling the mechanisms that underlie sensory and autonomic neurodegeneration could assist in identifying targets for future therapeutic strategies in patients with HSAN. This Review highlights key advances in the understanding of HSANs, including insights into the molecular mechanisms of disease, derived from genetic studies of patients with these disorders.
遗传性感觉和自主神经病(HSANs)是一组临床和遗传上具有异质性的周围神经系统疾病。进行性退化,主要是感觉和自主神经元的退化,是 HSAN 患者的主要病理特征,导致明显的感觉丧失和溃疡性残缺,同时伴有不同的自主和运动障碍。分子遗传学的进步使我们能够确定 12 个基因中的致病突变,并正在研究这些突变的功能影响。尽管一些受影响的蛋白质——如神经生长因子及其受体——具有明显的神经特异性作用,但其他是广泛表达的蛋白质,参与鞘脂代谢、囊泡运输、转录调节和结构完整性。未来的一个重要挑战将是了解导致 HSAN 的共同分子途径。阐明导致感觉和自主神经退行性变的机制,可以帮助确定 HSAN 患者未来治疗策略的靶点。这篇综述强调了对 HSAN 的理解的重要进展,包括从这些疾病患者的遗传研究中得出的对疾病分子机制的深入了解。